Cargando…

Hypoxia-mediated activation of hypoxia-inducible factor-1α in triple-negative breast cancer: A review

Triple-negative breast cancer (TNBC) is a subtype of breast cancer (BC) that is highly aggressive and hypoxic compared with other subtypes. The role of hypoxia-inducible factor 1α (HIF-1α) as a key hypoxic transcription factor in oncogenic processes has been extensively studied. Recently, it has bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lihui, Bai, Jie, Hu, Lanxin, Jiang, Daqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615493/ https://www.ncbi.nlm.nih.gov/pubmed/37904441 http://dx.doi.org/10.1097/MD.0000000000035493

Ejemplares similares

Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc
por: Cui, Jianxiu, et al.
Publicado: (2019)

Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer
por: Sjekloča, Nikoleta, et al.
Publicado: (2020)

Apatinib + CPT-11 + S-1 for treatment of refractory brain metastases in patient with triple-negative breast cancer: Case report and literature review
por: Hu, Ting, et al.
Publicado: (2018)

Rare metastasis to paranasal sinuses from triple-negative breast cancer: A case report and literature review
por: Xiong, Jie, et al.
Publicado: (2017)

Combination of Chinese medicinal formulas and chemotherapy for triple-negative breast cancer strengthens body resistance to eliminate pathogenic factors
por: Zhang, Yiyi, et al.
Publicado: (2022)

Expression analysis of E-cad and vascular endothelial growth factor in triple-negative breast cancer patients of different ethnic groups in western China
por: Jiang, Weihua, et al.
Publicado: (2017)

MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017)

Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database
por: Plasilova, Magdalena L., et al.
Publicado: (2016)

High expression of MORC2 predicts worse neoadjuvant chemotherapy efficacy in triple negative breast cancer
por: Liao, Xiaohong, et al.
Publicado: (2023)

Association Between Histone Methyltransferase hSETD1A and Prognosis in Patients With Triple-Negative Breast Cancer After Surgery: A Retrospective Study in the Chinese Female Population
por: Zhu, YanYan, et al.
Publicado: (2016)

Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis
por: Zhang, Shuo, et al.
Publicado: (2020)

Can we cure stage IV triple-negative breast carcinoma?: Another case report of long-term survival (7 years)
por: Chue, Ben Man-Fai, et al.
Publicado: (2019)

Expression of mammalian sterile 20-like kinase 1 and 2 and Yes-associated protein 1 proteins in triple-negative breast cancer and the clinicopathological significance
por: Feng, Yang, et al.
Publicado: (2021)

Positive estrogen receptor status is a poor prognostic factor in node-negative breast cancer: An observational study in Asian patients
por: Jung, Eun Jung, et al.
Publicado: (2021)

Application of the downgrade criteria to supplemental screening ultrasound for women with negative mammography but dense breasts
por: Kim, Soo-Yeon, et al.
Publicado: (2016)

Social isolation and cancer management after the 2011 triple disaster in Fukushima, Japan: A case report of breast cancer with patient and provider delay
por: Ozaki, Akihiko, et al.
Publicado: (2016)

Endocrine therapies in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative, pretreated, advanced breast cancer: A network meta-analysis
por: Lee, Cho-Hao, et al.
Publicado: (2020)

Potential association of prolonged patient interval and advanced anatomic stage in breast cancer patients in the area affected by the 2011 triple disaster in Fukushima, Japan: Retrospective observational study
por: Ozaki, Akihiko, et al.
Publicado: (2021)

Effect and safety of cytokine-induced killer (CIK) cell immunotherapy in patients with breast cancer: A meta-analysis
por: Hu, Jianxin, et al.
Publicado: (2017)

Better survival in PMRT of female breast cancer patients with >5 negative lymph nodes: A population-based study
por: Wang, Haiyong, et al.
Publicado: (2017)

Induced abortion and breast cancer: An updated meta-analysis
por: Deng, Yongchun, et al.
Publicado: (2018)

Associations Between Elastography Findings and Clinicopathological Factors in Breast Cancer
por: Hayashi, Mitsuhiro, et al.
Publicado: (2015)

Adjuvant ovarian suppression for premenopausal hormone receptor-positive breast cancer: A network meta-analysis
por: Jiang, Mengjie, et al.
Publicado: (2021)

Establishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy
por: Li, Jin-luan, et al.
Publicado: (2017)

Physical and psychological effects of different temperature-controlled breast prostheses on patients with breast cancer during rehabilitation: a randomized controlled study (CONSORT)
por: Qiu, Jiajia, et al.
Publicado: (2020)

Immediate breast reconstruction using latissimus dorsi muscular flap: A retrospective study of Chinese patients with breast cancer
por: Liu, Qiuming, et al.
Publicado: (2021)

The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer
por: Yen, Tina W.F., et al.
Publicado: (2016)

Utility of Red Cell Distribution Width as a Prognostic Factor in Young Breast Cancer Patients
por: Huang, Du-Ping, et al.
Publicado: (2016)

Impact of social and clinical factors on diagnostic delay of breast cancer: A Cross-sectional Study
por: Dianatinasab, Mostafa, et al.
Publicado: (2016)

A Case Report of Local Recurrence Developing 24 Years After Mastectomy for Breast Cancer Recurrence From Breast Cancer After 24 Years
por: Xiao, Linlin, et al.
Publicado: (2016)

Chemotherapy-induced prospective memory impairment in breast cancer patients with different hormone receptor expression
por: Li, Wen, et al.
Publicado: (2017)

Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy
por: Tasdoven, Ilhan, et al.
Publicado: (2022)

Phyllodes tumors of the breast in 2 sisters: Case report and review of literature
por: Wang, Yichao, et al.
Publicado: (2017)

Imaging features of granular cell tumor in the breast: Case report
por: Zeng, Qiao, et al.
Publicado: (2020)

Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors
por: Camacho, Fabian T., et al.
Publicado: (2017)

Preoperative predictive factors affecting sentinel lymph node positivity in breast cancer and comparison of their effectiveness with existing nomograms
por: Ceylan, Cengiz, et al.
Publicado: (2022)

Breast surgery for young women with early-stage breast cancer: Mastectomy or breast-conserving therapy?
por: Sun, Zhi-Hong, et al.
Publicado: (2021)

Extensive analysis of the molecular biomarkers excision repair cross complementing 1, ribonucleotide reductase M1, β-tubulin III, thymidylate synthetase, and topoisomerase IIα in breast cancer: Association with clinicopathological characteristics
por: Li, Juncheng, et al.
Publicado: (2021)

Analysis of factors influencing the degree of detectability on diffusion-weighted MRI and diffusion background signals in patients with invasive breast cancer
por: Hahn, Soo Yeon, et al.
Publicado: (2016)

Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: A case report
por: Dai, Jiali, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0qdtnmq30otubjpaa7qsin30o4